These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5157561)

  • 21. Further tests on the carcinogenicity of sorbic acid in the rat.
    Dickens F; Jones HE; Waynforth HB
    Br J Cancer; 1968 Dec; 22(4):762-8. PubMed ID: 5750785
    [No Abstract]   [Full Text] [Related]  

  • 22. Vitamin E influence on selected parameters in rats after ochratoxin A intoxication.
    Borzecki A; Borzecka H; Sobieszek-Dziuba U; Wilgat E; Sieklucka-Dziuba M
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():231-5. PubMed ID: 11977316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aflatoxin B1, ochratoxin A and rubratoxin B on infant rats.
    Hayes AW; Cain JA; Moore BG
    Food Cosmet Toxicol; 1977 Feb; 15(1):23-7. PubMed ID: 576860
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative responses to mode of oral administration and dose of ochratoxin A or nephrotoxic extract of Penicillium polonicum in rats.
    Miljkovic A; Pfohl-Leszkowicz A; Dobrota M; Mantle PG
    Exp Toxicol Pathol; 2003 Mar; 54(4):305-12. PubMed ID: 12710714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative damage and stress response from ochratoxin a exposure in rats.
    Gautier JC; Holzhaeuser D; Markovic J; Gremaud E; Schilter B; Turesky RJ
    Free Radic Biol Med; 2001 May; 30(10):1089-98. PubMed ID: 11369498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin a carcinogenicity in rat.
    Marin-Kuan M; Nestler S; Verguet C; Bezençon C; Piguet D; Mansourian R; Holzwarth J; Grigorov M; Delatour T; Mantle P; Cavin C; Schilter B
    Toxicol Sci; 2006 Jan; 89(1):120-34. PubMed ID: 16251485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro investigation of individual and combined cytotoxic effects of ochratoxin A and other selected mycotoxins on renal cells.
    Heussner AH; Dietrich DR; O'Brien E
    Toxicol In Vitro; 2006 Apr; 20(3):332-41. PubMed ID: 16140496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity.
    Adler M; Müller K; Rached E; Dekant W; Mally A
    Carcinogenesis; 2009 Apr; 30(4):711-9. PubMed ID: 19237604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary exposure to aflatoxin B
    Huong BTM; Tuyen LD; Tuan DH; Brimer L; Dalsgaard A
    Food Chem Toxicol; 2016 Dec; 98(Pt B):127-133. PubMed ID: 27746326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites?
    Zepnik H; Pähler A; Schauer U; Dekant W
    Toxicol Sci; 2001 Jan; 59(1):59-67. PubMed ID: 11134544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tubulotoxic mechanisms of ochratoxin A.
    Gekle M; Sauvant C; Schwerdt G; Silbernagl S
    Kidney Blood Press Res; 1998; 21(2-4):277-9. PubMed ID: 9762856
    [No Abstract]   [Full Text] [Related]  

  • 32. New mycotoxins from marine-derived fungus Aspergillus sp. SCSGAF0093.
    Xu X; He F; Zhang X; Bao J; Qi S
    Food Chem Toxicol; 2013 Mar; 53():46-51. PubMed ID: 23220611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in ochratoxin a toxicity in F344 rats after 7 and 21 days of daily oral administration.
    Pastor L; Vettorazzi A; Enciso JM; González-Peñas E; García-Jalón JA; Monreal JI; López de Cerain A
    Food Chem Toxicol; 2018 Jan; 111():363-373. PubMed ID: 29126803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is ochratoxin a nephrotoxic in human beings?
    Godin M; Fillastre JP; Simon P; Francois A; Roy FL; Morin JP
    Adv Nephrol Necker Hosp; 1997; 26():181-206. PubMed ID: 8922134
    [No Abstract]   [Full Text] [Related]  

  • 35. Ochratoxins.
    Applegate KL; Chipley JR
    Adv Appl Microbiol; 1973; 16():97-109. PubMed ID: 4584681
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk assessment of ochratoxin A: an update.
    Kuiper-Goodman T
    Food Addit Contam; 1996; 13 Suppl():53-7. PubMed ID: 8972354
    [No Abstract]   [Full Text] [Related]  

  • 37. [Mycotoxins as carcinogenic agents].
    Duraković S
    Lijec Vjesn; 1985; 107(11-12):530-7. PubMed ID: 3908865
    [No Abstract]   [Full Text] [Related]  

  • 38. Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model.
    Jennings P; Weiland C; Limonciel A; Bloch KM; Radford R; Aschauer L; McMorrow T; Wilmes A; Pfaller W; Ahr HJ; Slattery C; Lock EA; Ryan MP; Ellinger-Ziegelbauer H
    Arch Toxicol; 2012 Apr; 86(4):571-89. PubMed ID: 22124623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats.
    Aydin G; Ozçelik N; Ciçek E; Soyöz M
    Hum Exp Toxicol; 2003 Jul; 22(7):383-91. PubMed ID: 12929728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogenicity of 4-nitroquinoline 1-oxide analogs: pyridine series.
    Araki M; Koga C; Kawazoe Y
    Gan; 1971 Aug; 62(4):325-7. PubMed ID: 5094172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.